Literature DB >> 9107109

Bilateral, perisylvian and rolandic cortical dysplasia in trisomy 13 syndrome.

R N Sener1.   

Abstract

In patients with the trisomy 13 syndrome the most commonly encountered brain anomaly is holoprosencephaly, which occurs in approximately 80% of cases. In trisomy 13 patients without holoprosencephaly, previously reported anomalies include callosal dysgenesis, hippocampal hypoplasia, olfactory hypoplasia, and cerebellar dysplastic changes such as vermian hypoplasia and dysplastic cortices. Dysplasia of the cerebral cortex, however, has not been reported before. We describe a newborn with bilateral, dysplastic cortices at the perisylvian and rolandic regions. These dysplastic cortices probably accounted for the clinical findings of seizures, oromotor dysfunction, dystonia flexion contractures in the hands, which were consistent with a recently described syndrome labelled as the "congenital bilateral perisylvian syndrome".

Entities:  

Mesh:

Year:  1996        PMID: 9107109

Source DB:  PubMed          Journal:  J Neuroradiol        ISSN: 0150-9861            Impact factor:   3.447


  4 in total

Review 1.  Genetics of the polymicrogyria syndromes.

Authors:  A Jansen; E Andermann
Journal:  J Med Genet       Date:  2005-05       Impact factor: 6.318

2.  Congenital bilateral perisylvian syndrome with pituitary hypoplasia and ectopic neurohypophysis.

Authors:  Ensar Yekeler; Meral Ozmen; Hakan Genchellac; Memduh Dursun; Gulden Acunas
Journal:  Pediatr Radiol       Date:  2004-05-28

3.  The Genetic Landscape of Polymicrogyria.

Authors:  Jesmy James; Mary Iype; Mithran Omana Surendran; Ayyappan Anitha; Sanjeev V Thomas
Journal:  Ann Indian Acad Neurol       Date:  2022-05-05       Impact factor: 1.714

4.  Partial trisomy 13q22-qter associated to leukoencephalopathy and late onset generalised epilepsy.

Authors:  Renee Ribacoba; Manuel Menendez-Gonzalez; Ines Hernando; Javier Salas; Maria Luisa Giros
Journal:  Int Arch Med       Date:  2008-04-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.